CCMH
HRTX icon

Cornerstone Capital Management Holdings’s Heron Therapeutics HRTX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-400
Closed -$10K – 1488
2015
Q3 		$10K Buy
+400
New +$13.3K ﹤0.01% 1473

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Capital Management Holdings's HRTX Position: Q4 2015 in Review

Cornerstone Capital Management Holdings sold out of Heron Therapeutics (HRTX) in Q4 2015, closing a stake of 400 shares — an estimated $10K sold.

Cornerstone Capital Management Holdings first reported a position in HRTX in Q3 2015 and held it in 1 quarter. The position peaked at $10K in Q3 2015. 107 funds tracked by Wall St. Rank hold HRTX as of Q4 2015.

  • Cornerstone Capital Management Holdings reported no remaining Heron Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 400 Heron Therapeutics shares in Q4 2015, an estimated $10K.
  • Cornerstone Capital Management Holdings first reported a position in Heron Therapeutics in Q3 2015 and held it in 1 quarter.
  • Cornerstone Capital Management Holdings's Heron Therapeutics position peaked at $10K in Q3 2015.
  • 107 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2015, filed 9 Feb 2016.